Patterns and determinants of compliance with inhaled steroids in adults with asthma

Canadian Respiratory Journal

Volumn 12, Issue 4, 2005, Pages 211-217

  Lacasse, Yves ^a   Archibald, Hélène ^b   Ernst, Pierre ^c   Boulet, Louis Philippe ^a  

^a LAVAL UNIVERSITY   (Canada)

^b Service de Pneumologie   (Canada)

^c MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

Asthma; Compliance; Inhaled corticosteroids

Indexed keywords

CORTICOSTEROID; FLUTICASONE;

ADULT; AGE; ARTICLE; ASTHMA; CANADA; CORTICOSTEROID THERAPY; DRUG DOSE REGIMEN; FEMALE; HUMAN; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; PATIENT ATTITUDE; PATIENT COMPLIANCE; PRESCRIPTION; PRIORITY JOURNAL; QUESTIONNAIRE;

EID: 23044500224     PISSN: 11982241     EISSN: None     Source Type: Journal    
DOI: 10.1155/2005/375454     Document Type: Article

References (37)

1. Haynes RB. Compliance in Health Care. Baltimore: Johns Hopkins University Press, 1979:1-7.
2. Cochrane GM. Observance and outcomes in patients with asthma. Drugs 1996;52(Suppl 6):12-9.
3. Lemière C, Bai T, Balter M, et al. Adult Asthma Consensus Guidelines Update 2003. Can Respir J 2004;11(Suppl A):9A-18A.
4. Juniper EF, Kline PA, Vanzieleghem MA, Ramsdale EH, O'Byrne PM, Hargreave FE. Effect of long-term treatment with inhaled corticosteroid (budesonide) on airway hyperresponsiveness and clinical asthma in nonsteroid-dependent asthmatics. Am Rev Respir Dis 1990;142:832-6.
5. Adams NP, Bestall JP, Jones PW. Inhaled beclomethasone at different doses for long-term asthma. Cochrane Database Syst Rev 2001;(1):CD002879.
6. Adams NP, Bestall JP, Jones PW. Fluticasone versus beclomethasone or budesonide for chronic asthma. Cochrane Database Syst Rev 2002;(1):CD002310. (Update in 2004;(2):CD002310)
7. Adams N, Bestall JM, Jones PW. Inhaled beclomethasone versus budesonide for chronic asthma. Cochrane Database Syst Rev 2002;(1):CD003530.
8. Spector S. Noncompliance with asthma therapy - are there solutions? J Asthma 2000;37:381-8.
9. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986. Am Rev Respir Dis 1987;136:225-44.
10. Guillemin F, Bombardier C, Beaton D. Cross-cultural adaptation of health-related quality of life measures: Literature review and proposed guidelines. J Clin Epidemiol 1993;46:1417-32.
11. Nides MA, Tashkin DP, Simmons MS, Wise RA, Li VC, Rand CS. Improving inhaler adherence in a clinical trial through the use of the nebulizer chronolog. Chest 1993;104:501-7.
12. Levine RJ. Monitoring for adherence: Ethical considerations. Am J Respir Crit Care Med 1994;149:287-8.
13. Juniper EF, O'Byrne PM, Guyatt GH, Ferrie PJ, King DR. Development and validation of a questionnaire to measure asthma control. Eur Respir J 1999;14:902-7.
14. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986;24:67-74.
15. Bender B, Wamboldt FS, O'Connor SL, et al. Measurement of children's asthma medication adherence by self report, mother report, canister weight, and Doser CT. Ann Allergy Asthma Immunol 2000;85:416-21.
16. Hsieh FY. Sample size tables for logistic regression. Stat Med 1989;8:795-802.
17. Brueckner JW, Marshik F, Sherman J, Hendeles L. Reliability of the Medtrac MDI Chronolog. J Allergy Clin Immunol 1997;100:488-91.
18. Wamboldt FS, Bender BG, O'Connor SL, et al. Reliability of the model MC-311 MDI chronolog. J Allergy Clin Immunol 1999;104:53-7.
19. Julius SM, Sherman JM, Hendeles L. Accuracy of three electronic monitors for metered-dose inhalers. Chest 2002;121:871-6.
20. Spector SL, Kinsman R, Mawhinney H, et al. Compliance of patients with asthma with an experimental aerosolized medication: Implications for controlled clinical trials. J Allergy Clin Immunol 1986;77:65-70.
21. Bosley CM, Fosbury JA, Cochrane GM. The psychological factors associated with poor compliance with treatment in asthma. Eur Respir J 1995;8:899-904.
22. Apter AJ, Reisine ST, Affleck O, Barrows E, ZuWallack RL. Adherence with twice-daily dosing of inhaled steroids: Sociodemographic and health-belief differences. Am J Respir Crit Care Med 1998;157:1810-7.
23. Milgrom H, Bender B, Ackerson L, Bowry P, Smith B, Rand C. Noncompliance and treatment failure in children with asthma. J Allergy Clin Immunol 1996;98:1051-7.
24. Hindi-Alexander M. Compliance or noncompliance: That is the question! Am J Health Promot 1987;1:5-11.
25. van der Palen J, Klein JJ, Rovers MM. Observance with inhaled medication and self-treatment guidelines following a self-management programme in adult asthmatics. Eur Respir J 1997;10:652-7.
26. Bosley GM, Parry DT, Cochrane GM. Patient compliance with inhaled medication: Does combining beta-agonists with corticosteroids improve compliance? Eur Respir J 1994;7:504-9.
27. Desjardins A, Benoit C, Ghezzo H, et al. Exposure to domestic animals and risk of immunologic sensitization in subjects with asthma. J Allergy Clin Immunol 1993;91:979-86.
28. Verschelden P, Cartier A, L'Archeveque J, Trudeau C, Malo JL. Compliance with and accuracy of daily self-assessment of peak expiratory flows (PEF) in asthmatic subjects over a three month period. Eur Respir J 1996;9:880-5.
29. Standardization of Spirometry, 1994 Update. American Thoracic Society. Am J Respir Crit Care Med 1995;152:1107-36.
30. Juniper EF, Buist AS, Cox FM, Ferrie PJ, King DR. Validation of a standardized version of the Asthma Quality of Life Questionnaire. Chest 1999;115:1265-70.
31. Boulet LP. Perception of the role and potential side effects of inhaled corticosteroids among asthmatic patients. Chest 1998;113:587-92.
32. Hand CH, Bradley C. Health beliefs of adults with asthma: Toward an understanding of the difference between symptomatic and preventive use of inhaler treatment. J Asthma 1996;33:331-8.
33. Osman LM, Russell IT, Friend JA, Legge JS, Douglas JG. Predicting patient attitudes to asthma medication. Thorax 1993;48:827-30.
34. Lévesque L, Desharnais R, Godin G. Validation canadienne-française du self-control schedule. Science Comportement 1995;24:133-49.
35. Rosenbaum M. A schedule for assessing self-control behaviors: Preliminary findings. Behav Ther 1980;11:109-21.
36. Spielberger CD, Gorsuch RL, Lushene RE, et al. Manual of the State-Trait Anxiety Inventory. Palo Alto: Consulting Psychologists Press, 1983.
37. Derogatis LR, Cleary PA. Confirmation of the dimensional structure of the SCL-90: A study in construct validity. J Clin Psychol 1977;33:981-9.